Sumitomo Mitsui Trust Holdings Inc. lowered its position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 0.7% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 141,119 shares of the medical research company’s stock after selling 1,066 shares during the period. Sumitomo Mitsui […]
Charles River Laboratories International, Inc. (NYSE:CRL – Get Free Report) has earned an average rating of “Moderate Buy” from the nine analysts that are currently covering the company, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company. The average 12-month […]
Ariel Investments LLC trimmed its holdings in Charles River Laboratories International, Inc. (NYSE:CRL – Get Rating) by 2.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 637,762 shares of the medical research company’s stock after selling 12,736 shares during the period. […]
Heritage Wealth Management LLC grew its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Get Rating) by 149.2% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,710 shares of the medical research company’s stock after buying an additional […]
Shaker Investments LLC OH raised its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Get Rating) by 323.1% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 9,866 shares of the medical research company’s stock after buying an additional 7,534 shares […]